Sergamumo ir pirmalaikio mirtingumo nuo kraujotakos sistemos ligų mažinimo krypties aprašas

Objectives

The framework seeks to reduce morbidity and premature mortality from circulatory-system diseases, especially cardiovascular disease among working-age people and residents of target territories, by strengthening prevention, risk-factor management, early diagnosis, timely treatment and equitable access to high-quality care.[1][2][3]It aims to enable people to remain healthy, independent and economically active for longer while reducing health-related social exclusion.[1]

• Prioritise primary and secondary prevention of smoking, dyslipidaemia, hypertension, unhealthy diet, physical inactivity, overweight and obesity, alcohol-related harm, occupational stress and exposure to tobacco smoke.[4][5][6]
• Improve health literacy, lifestyle skills, community prevention, patient empowerment and healthier food environments, including promotion of the voluntary “Keyhole” symbol for healthier foods.[7][6][8]
• Expand the national cardiovascular disease prevention programme beyond its original coverage of women aged 50–65 and men aged 40–55 without diagnosed cardiovascular disease, and make services available at least in county centres.[9][10]
• Strengthen early detection and treatment of atherosclerotic disease, acute coronary syndromes, atrial fibrillation, hypertension, dyslipidaemia and heart failure, including measures to delay heart-failure onset, reduce complications and avoid repeat admissions.[11][12]
• Establish an integrated, sustainable cardiovascular-care system spanning public health, primary care, secondary outpatient cardiology, tertiary interventional and surgical care, rehabilitation, emergency transport, mobile services and telemedicine.[13][14][15]
• Reduce geographical inequality by concentrating measures in district municipalities where standardised cardiovascular mortality among people aged 0–64 was at least 20% above the national average during 2007–2011, with later extension to other areas according to mortality indicators.[1]

The framework sets measurable ambitions for target territories, including reducing standardised circulatory-disease mortality among people aged 0–64 from 158.91 per 100,000 in 2012 to 105 by 2023, and increasing prevention-programme participation from 22.3% in 2012 to 40% by 2023.[16]It also seeks gradual annual improvements in obesity, overweight, physical inactivity, smoking, and fruit and vegetable consumption.[16]

Implementation

Implementation combines territorially targeted action, national health-system reform and locally delivered prevention and care.[17]The model links municipal public-health bureaux and primary-care providers with secondary, regional and university-hospital services, supported by standardised pathways, workforce development, infrastructure modernisation, information systems and coordinated patient transport.[18][14][19]

• Coordinate delivery through the Ministry of Health and its subordinate institutions, the National Health Insurance Fund, municipalities, public-health bureaux, primary and specialist healthcare providers, university and regional hospitals, universities, research institutions, non-governmental organisations, communities, employers and professional associations.[18][20]
• Develop and apply integrated prevention, diagnosis, treatment, rehabilitation, referral and patient-flow models, connecting risk assessment and lifestyle support with stepped diagnostics, specialist consultation and interventional inpatient care.[14][21]
• Standardise care through nationally applicable algorithms, methodologies and protocols for cardiovascular prevention, surveillance, service management and clinical conditions including myocardial infarction, atrial fibrillation and heart failure.[11][22]
• Strengthen primary care by training family-medicine doctors, community nurses and public-health specialists; revising relevant family-medicine and reimbursement arrangements; and improving diagnostic capacity, electronic data exchange, referral communication and treatment-plan follow-up.[23][24][25]
• Expand specialised prevention centres and outpatient cardiology capacity, including equipment for echocardiography, Holter monitoring, ambulatory blood-pressure monitoring, exercise testing and early atherosclerosis assessment.[10]
• Provide multidisciplinary heart-failure services across inpatient and outpatient settings, including diagnosis, treatment, continuing follow-up, palliative care and patient education.[26]
• Deploy mobile cardiology teams and teleconsultations where permanent outpatient cardiologists are unavailable, while strengthening emergency medical-service competence, ambulance equipment and inter-facility patient-transfer arrangements.[27][19]
• Use electronic referrals, interoperable patient information, remote communication, telemedicine and wearable technologies to improve patient-flow management, urgent-care pathways and chronic-disease monitoring.[28][29]
• Support practical health education through seven thematic training rooms, continuing professional development, workplace initiatives, food-industry engagement and pilots of individual public-health counselling and early tobacco and alcohol diagnostic measures.[30][8][24]

Performance assessment covers mortality, prevention-programme participation, lifestyle risk factors, service access and use, waiting times, workforce training, infrastructure, protocol uptake, time to intervention and clinical outcomes such as 30-day survival after myocardial infarction.[15][31]Targeted operational indicators include reducing average outpatient cardiology waiting time from 19 days in 2013 to 15 days in 2023, delivering at least 10 mobile-service consultations per working day, and applying approved protocols in at least 90% of relevant public healthcare institutions.[32][22]Achievement of outcome indicators is to be evaluated in 2019 and 2023, with annual monitoring of evaluation criteria and revision of measures where results or implementation needs require it.[21]

Financing includes historical European Union Structural Funds investments in regional cardiology and municipal public-health infrastructure, as well as Ministry of Health funding for the prevention programme.[9][13][33]Up to 85 million Lithuanian litas is planned for the measures in this area, with infrastructure funding intended to follow assessment of existing capacity, utilisation and previous investments, and with avoidance of duplicate funding for overlapping risk-factor measures.[34]

Monitoring & Evaluation

Monitoring combines baseline burden analysis, risk-factor surveillance, service-use measures and outcome indicators, with increasingly explicit targets for targeted territories. However, many action areas do not define reporting cycles, evaluation methods, surveillance arrangements or formal accountability procedures.[1][15][31][16]

• Use cardiovascular mortality, ischaemic heart disease mortality, premature mortality and standardised mortality among people aged 0–64 years to identify inequalities and assess progress. During 2007–2011, 23 municipalities recorded standardised cardiovascular mortality at least 20% above the national average, with rates of 158.91 in these municipalities and 128.17 nationally.[26][35]
• Monitor prevention-programme coverage, risk-factor prevalence and referral patterns. Among programme participants during 2009–2012, hypertension declined from 60.2% to 54.5%, metabolic syndrome from 34.1% to 28.7%, mean body-mass index from 29.17 kg/m² to 28.92 kg/m², and abdominal obesity from 48.4% to 45.3%; dyslipidaemia remained above 80% among middle-aged participants.[36]
• Track population lifestyle risks using evidence such as the 2007 survey finding overweight among 38.6% of the population and obesity among 13.5% of adults, and the 2010–2011 physical-activity study of 1,038 residents aged 15–74.[37][38]
• Establish continuous municipality-level monitoring of smoking, overweight and physical inactivity to assess the effectiveness of public-health bureaux, particularly in target areas. The Ministry of Health or its subordinate institutions, municipal administrations and public-health bureaux are identified for this activity.[8]
• Monitor implementation periodically and use evidence reviews and one- to two-year pilots to identify effective interventions for physical activity, smoking reduction and individual public-health counselling.[39][5][6]
• Evaluate pilot early tobacco- and alcohol-diagnostic measures for effectiveness and practical applicability before national expansion.[24]
• Apply integrated criteria for cardiovascular and cerebrovascular risk factors, including hospitalisation among people with arterial hypertension and population lifestyle changes, to assess implementation and results.[40]
• Measure mortality, prevention-programme participation, lifestyle change, service access, workforce development, infrastructure, care processes and clinical outcomes. Specified measures include cardiology visits, telemedicine and mobile-clinic activity, outpatient waiting times, timely intervention, time from myocardial-infarction symptoms to percutaneous transluminal coronary angioplasty, and 30-day survival after myocardial infarction.[15][31]
• Target by 2023 a standardised circulatory-disease mortality rate of 105 per 100,000 people aged 0–64, compared with 158.91 in 2012; prevention-programme participation of 40%, compared with 22.3% in 2012; and 0.17 cardiology visits per resident, compared with 0.14 in 2012.[16]
• Reduce average tertiary-level consultation referrals from 137 patients in 2013 to 116 in 2023, and pursue annual lifestyle improvements from the 2015 baseline, including reductions in obesity, overweight, low physical activity and daily smoking and increased fruit and vegetable consumption.[16]
• Monitor service expansion through targets for outpatient cardiology activity, access for up to 600,000 residents in target territories, 6 to 10 prevention consultations per 10,000 residents annually, at least 10 mobile-service consultations per working day, and protocol use in at least 90% of relevant public healthcare institutions.[32][22]
• Evaluate outcome-indicator achievement in 2019 and 2023, monitor evaluation criteria annually, and revise measures where results or implementation needs warrant changes.[21]
• Recognise data limitations: principal-diagnosis death registration does not establish the true mortality of people with heart failure, and official statistics on repeat heart-failure hospitalisations had not been published.[12][41]

Costing & Financing

Financing is mainly described through Ministry of Health funding, European Union Structural Funds and a planned overall allocation, while most actions lack detailed budgets, unit costs, funding-gap estimates or economic assumptions.[9][13][33][34]

• Finance the national cardiovascular disease prevention programme through the Lithuanian Ministry of Health.[9]
• Use European Union Structural Funds for regional cardiology infrastructure, including 83.4 million Lithuanian litas for the Eastern and South-Eastern Lithuania project in 2004–2006 and 156.4 million Lithuanian litas for the Central and Western Lithuania project in 2007–2013.[13][33]
• Invest more than 15 million Lithuanian litas in municipal public-health infrastructure, creating or refurbishing 27 public-health bureaux.[33]
• Provide European Union structural-fund support for partial renewal of emergency medical transport capacity during 2007–2013, although no monetary allocation is given.[3]
• Plan up to 85 million Lithuanian litas for measures in this area, while considering planned service development in State Patient Fund financing.[34]
• Allocate resources without duplicating funding for measures addressing shared cardiovascular and cerebrovascular risk factors, and assess existing infrastructure, utilisation and results of 2004–2006 and 2007–2013 investments before further modernisation funding.[34]
• Recognise heart-failure care as a significant expenditure area: European and American countries allocate up to 3% of total health expenditure to this care, while no Lithuanian monetary amount is provided.[12]
• Identify resource needs for training, diagnostic equipment, teleconsultation systems, mobile services, ambulances, public-health facilities and specialised prevention centres, but leave their costs, financing sources and recurrent funding unspecified in most sections.[30][25][10][27][19][40]